Halozyme Therapeutics (HALO) Net Margin (2010 - 2026)
Halozyme Therapeutics' (HALO) quarterly Net Margin came in at 39.83% in Q1 2026, down 476.0% year-on-year from 10.59% in Q1 2025, and up 227.09% on a QoQ basis from 31.34% in Q4 2025.
Halozyme Therapeutics (HALO) Net Margin (2010 - 2026) Analysis & Trends
Halozyme Therapeutics (HALO) has 17 years of Net Margin data on file, last reported at 39.83% in Q1 2026.
- On a quarterly basis, Net Margin fell 476.0% year-over-year to 39.83% in Q1 2026; TTM through Mar 2026 was 23.13%, a 2163.0% decrease from a year earlier, with the FY2025 full-year figure at 22.69%, down 2105.0% from the prior year.
- Net Margin for Q1 2026 stood at 39.83%, up from 31.34% in the prior quarter.
- Over the last five years, Net Margin for HALO reached as high as 51.25% in Q1 2022 and fell as low as 31.34% in Q4 2025.
- Historically, Net Margin has averaged 34.51% across 5 years, with a median of 39.22% in 2024.
- On a YoY basis, Net Margin climbed as much as 1992 bps in 2022 and fell as far as 15749 bps in 2022.
- Year by year, Net Margin stood at 31.79% in 2022, then advanced by 17 bps to 37.12% in 2023, then gained by 24 bps to 45.98% in 2024, then slumped by 168 bps to 31.34% in 2025, then surged by 227 bps to 39.83% in 2026.
- Per Business Quant data, the three most recent Net Margin figures were 39.83% in Q1 2026, 31.34% in Q4 2025, and 49.47% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Halozyme Therapeutics | 9.55 Bn | 9.23 Bn | 297.47 Mn | 39.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.83% |
| Dec 31, 2025 | -31.34% |
| Sep 30, 2025 | 49.47% |
| Jun 30, 2025 | 50.71% |
| Mar 31, 2025 | 44.59% |
| Dec 31, 2024 | 45.98% |
| Sep 30, 2024 | 47.23% |
| Jun 30, 2024 | 40.30% |
| Mar 31, 2024 | 39.22% |
| Dec 31, 2023 | 37.12% |
| Sep 30, 2023 | 37.88% |
| Jun 30, 2023 | 33.82% |
| Mar 31, 2023 | 24.43% |
| Dec 31, 2022 | 31.79% |
| Sep 30, 2022 | 29.49% |
| Jun 30, 2022 | 14.89% |
| Mar 31, 2022 | 51.25% |
| Dec 31, 2021 | 65.46% |
| Sep 30, 2021 | 186.99% |
| Jun 30, 2021 | 67.02% |